Laboratory of Physiology and Functional Explorations, Faculty of Medicine Ibn El-Jazzar, Tunisia.
J Endocrinol Invest. 2009 Sep;32(8):671-6. doi: 10.1007/BF03345739. Epub 2009 Apr 7.
The aim of the present study is to establish age- and sex-related reference ranges of serum IGF-I and IGF binding protein-3 (IGFBP-3) levels in a pattern of Tunisian children.
Two hundred healthy Tunisian children (103 boys and 97 girls), aged between 6 and 16 yr, were considered in the study.
Mean serum levels of IGF-I and IGFBP-3 are observed to be higher in girls compared to boys of the same age interval. However, these differences were statistically significant only in pubertal ages (11-14 yr) for IGF-I and in pre-pubertal ages (6-10 yr) for IGFBP- 3 (p<0.05). Steeper variations in IGF-I concentrations were obtained earlier in girls than in boys (11-12 vs 12-13 yr, Tanner stage 3-4). Peak of IGF-I levels are observed at almost the same age interval (12-14 yr). IGFBP-3 levels significantly increased at steeper variations of IGF-I for both sexes followed by steady values.
Variations of IGF-I and IGFBP- 3 with the considered parameters (sex, age, and puberty stage), which concord with previous studies on various populations, emphasize the importance of locally established reference levels to construct a SD score prediction model. Establishment of reference serum IGF-I and IGFBP-3 ranges during childhood and adolescence in Tunisian subjects can help to enhance the diagnostic efficiency of IGF-I and IGFBP-3 in evaluating growth disorders in our population.
本研究旨在建立一套与年龄和性别相关的血清 IGF-I 和 IGF 结合蛋白-3(IGFBP-3)水平的参考范围,该范围适用于突尼斯儿童群体。
本研究纳入了 200 名健康的突尼斯儿童(103 名男孩和 97 名女孩),年龄在 6 至 16 岁之间。
研究发现,同年龄段的女孩血清 IGF-I 和 IGFBP-3 水平高于男孩,但这些差异仅在青春期(11-14 岁)时 IGF-I 和青春期前(6-10 岁)时 IGFBP-3 具有统计学意义(p<0.05)。女孩 IGF-I 浓度的变化比男孩更早(11-12 岁比 12-13 岁,Tanner 分期 3-4)。IGF-I 水平的峰值出现在几乎相同的年龄区间(12-14 岁)。IGFBP-3 水平在 IGF-I 浓度变化较大时显著升高,随后趋于稳定。
IGF-I 和 IGFBP-3 的变化与考虑的参数(性别、年龄和青春期阶段)相关,这与之前对不同人群的研究结果一致,强调了建立本地参考水平的重要性,以构建 SD 评分预测模型。在突尼斯人群中建立儿童和青少年时期的血清 IGF-I 和 IGFBP-3 参考范围,可以提高 IGF-I 和 IGFBP-3 在评估我们人群中生长障碍方面的诊断效率。